PDCD1 and colitis: All three frequentist estimators gave τ^  = 0 and estimated the overall OR as 3.39 with 95% CI [1.45, 7.95], indicating that patients that were treated with anti-PD-1 drugs were at significantly higher risk of developing colitis as compared with those in the control group.